A group of researchers have developed a vaccine that is effective in mice against Powassan virus, an emerging tick-borne virus that can cause life-threatening encephalitis in humans. They also show that the vaccine produces antibodies that can protect the mice against other, related tick-transmitted flaviviruses. Their findings appear in the journal Cell Reports.
Powassan (POWV) virus, a member of the flavivirus family to which Zika belongs, is still rare, but it can be deadly--and as with many emerging diseases, there was previously no known prevention or treatment for it. This new vaccine is based on a vaccine platform that the reearchers used to develop a potential vaccine for Zika: mRNA from the virus in question, encapsulated in lipid nanoparticles (LNP), produces subviral particles that share many features of the virus and provoke an immune reaction that produces protective antibodies.
The POWV mRNA vaccine induced high titers of neutralizing antibody and sterilizing immunity against lethal challenge with different POWV strains. In mice, the new vaccine was effective after one dose against two different strains of Powassan virus and against the more distantly related Langat virus.
This work suggests that the LNP-encapsulated modified mRNA vaccine platform could be used to produce vaccine candidates for other flaviviruses by substituting in mRNA from the virus the researchers want to target. The researchers hope that this could be a way to rapidly produce potential vaccines for new flaviviruses as they emerge and before they become epidemics.
"We are excited that this mRNA-based vaccine against Powassan virus was highly immunogenic and conferred protection against multiple members of the family. We plan to continue studying the molecular basis for its broadly neutralizing antibody activity and test the vaccine against additional related viruses," the senior author says.
https://www.cell.com/cell-reports/fulltext/S2211-1247(18)31873-4?_
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fan-mrna-vaccine&filter=22
Latest News
Paranoia in the brain
By newseditor
Posted 16 Jun
In-vitro 3D culture of func…
By newseditor
Posted 15 Jun
Neural balance in the brain…
By newseditor
Posted 15 Jun
Antimalarial compounds reli…
By newseditor
Posted 15 Jun
3D imaging of whole human b…
By newseditor
Posted 14 Jun
Other Top Stories
The mechanisms behind swallowing
Read more
Deep-brain stimulation during sleep strengthens memory
Read more
How Botox enters the brain cells
Read more
Low-flavanol diet drives age-related memory loss
Read more
NLRP12 as a new drug target for infection, inflammation and hemolyt…
Read more
Protocols
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Analysis of 3D pathology sa…
By newseditor
Posted 08 Jun
Long-term expandable mouse…
By newseditor
Posted 07 Jun
Publications
NRG1-ErbB4 signaling in the…
By newseditor
Posted 15 Jun
HPV integration and cervica…
By newseditor
Posted 15 Jun
Cerebral tau pathology in c…
By newseditor
Posted 15 Jun
Cerebral tau pathology in c…
By newseditor
Posted 15 Jun
Synthetic biodegradable mic…
By newseditor
Posted 15 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar